Ohio State Navbar

Sign In

Archives

June 2017 (4)
May 2017 (1)
March 2017 (6)
January 2017 (1)
December 2016 (1)
November 2016 (3)
October 2016 (3)
September 2016 (1)
August 2016 (4)
July 2016 (5)
June 2016 (9)
May 2016 (8)
March 2016 (2)
February 2016 (4)
December 2015 (4)
November 2015 (3)
October 2015 (2)
September 2015 (4)
July 2015 (7)
June 2015 (3)
May 2015 (7)
April 2015 (3)
March 2015 (2)
February 2015 (2)
January 2015 (2)
December 2014 (3)
November 2014 (8)
October 2014 (7)
September 2014 (3)
August 2014 (7)
July 2014 (4)
June 2014 (3)
May 2014 (1)
April 2014 (3)
March 2014 (6)
February 2014 (4)
January 2014 (1)
December 2013 (6)
November 2013 (4)
October 2013 (1)
September 2013 (1)
August 2013 (9)
July 2013 (1)
June 2013 (9)
May 2013 (14)
April 2013 (13)
March 2013 (9)
February 2013 (8)
January 2013 (6)
December 2012 (7)
November 2012 (7)
October 2012 (9)
September 2012 (6)
August 2012 (12)
July 2012 (6)
June 2012 (8)
May 2012 (14)
April 2012 (7)
March 2012 (4)
February 2012 (11)
January 2012 (8)
December 2011 (5)
November 2011 (7)
October 2011 (9)
September 2011 (5)
August 2011 (3)
July 2011 (8)
June 2011 (1)
May 2011 (10)
April 2011 (4)
March 2011 (5)
February 2011 (9)
January 2011 (2)
December 2010 (2)
November 2010 (3)
September 2010 (4)
August 2010 (6)
July 2010 (6)
June 2010 (6)
May 2010 (1)
April 2010 (3)
February 2010 (3)
January 2010 (2)
December 2009 (3)
September 2009 (6)
August 2009 (1)
July 2009 (2)

Categories


RSS Feed College of Medicine News


$1.7M Grant Awarded to Further Research in Liver Function 

 

Principal Investigators Clark Anderson, MD, Latha Ganesan, PhD, and John Robinson, PhD have acquired a five-year RO1 grant ($1.7 million total) from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) for “ Immune Complex Elimination by Sinusoid Endothelial FcgRIIb: Mechanism and Disease.”

The NIAMS grant will mark Anderson’s 40th year of continuous RO1 grant funding from the National Institutes of Health (NIH). Funding will be used to facilitate the continued investigation of how the liver acts as a garbage dump for the body.

Two types of cells line the liver’s blood vessels: endothelium and macrophages. Endothelium constitutes the boundary of the blood vessels while macrophages rest upon them. Macrophages have formerly been recognized as the main scavengers of harmful immune complexes in the blood; however, these workers have discovered that endothelium is just as important and perhaps more so. While macrophages take up large immune complexes, the fate of the small immune complexes has remained unknown.

Preliminary data show that liver sinusoidal endothelial cells (LSEC) have a prominent function in the liver’s garbage disposal-like functions. LSEC express molecular structures called Fc receptors, which are known to take up antigen-antibody (immune) complexes. This team of researchers has found that a specific Fc receptor, FcgRII (RIIb), is the scavenger of LSEC responsible for taking up small immune complexes that cause diseases like glomerulonephritis and systemic lupus erythematosus.

The grant has four aims, First, to test the hypothesis that RIIb of LSEC eliminates small immune complexes from the blood; second, to isolate and purify scavenger cells from the liver; third, to show that elimination of small immune complexes by RIIb of LSEC is efficient, fast and robust; and finally, to show that RIIb controls the manifestation of immune complex-mediated disease.

Knockout mice will be used to characterize the mechanisms that mediate RIIb scavenger activity. “These mechanisms are the biology of the body,” says Anderson. “We are basic scientists interested in studying how the body works. If we can understand these mechanisms, we can apply these principles to specific diseases.”

 

Posted on 30-Jul-14 by OSUMC\mcga17
Tags:
 
Trackback Url  |  Link to this post | Bookmark this post with: